Meglumine Antimonate
Who holds supplier records for Meglumine Antimonate? 1 organisation holds a current record for Meglumine Antimonate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: United States (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Meglumine Antimonate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/meglumine-antimonate
Reading the evidence
- One current record
One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.
- No company-level GMP certificate matched
No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.
Current records (1)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Meglumine Antimonate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Sanofi-Aventis U.S. LLCUnited StatesActive DMF 36014 · latest filing Oct 2021
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Overview
Meglumine Antimonate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL239129).
Chemical identity
- IUPAC name
- hydroxy(dioxo)-lambda5-stibane;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
- Canonical SMILES
- CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.O[Sb](=O)=O
- InChIKey
- XOGYVDXPYVPAAQ-SESJOKTNSA-M
- Synonyms
- Glucantim, Glucantime, Meglumine antimonate, Meglumine antimoniate, N-methylglucamine antimonate, N Methylglucamine Antimonate, RefChem:156280, Methylglucamine antimonate, Protostib, n-methyl glucamine antimoniate, N-Methylgluamine Antimoniate, N-methylglucamine antimoniate
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Meglumine Antimonate?
1 organisation holds an active US FDA Type II Drug Master File or a CEP for Meglumine Antimonate: Sanofi-Aventis U.S. LLC (United States). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Meglumine Antimonate Drug Master Files are active?
Sanofi-Aventis U.S. LLC (DMF 36014). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Meglumine Antimonate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Meglumine Antimonate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.